This was the stock's second consecutive day of gains.

Amgen Inc. (NASDAQ:AMGN) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, UBS ...

Amgen Inc (NASDAQ:AMGN) shares held near flat in after-hours trading Tuesday despite posting better-than-expected quarterly ...

Amgen Inc. (NASDAQ:AMGN) is one of the top cheap pharmaceutical stocks to buy now. Leerink Partners analyst David Risinger ...

This was the stock's third consecutive day of losses.

Amgen Inc. boosted its 2025 guidance after quarterly results beat Wall Street’s estimates on the back of strong sales from older medicines such as the cholesterol-lowering drug Repatha.

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

On July 16, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a settlement ...

In a recently-issued Director Discretionary Denial decision, U.S. Patent and Trademark Office (USPTO) Acting Director Coke ...

In the latest close session, Amgen (AMGN) was down 1.73% at $301.29. The stock's change was less than the S&P 500's daily ...

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

Amgen (AMGN) Declines More Than Market: Some Information for Investors July 18, 2025 — 05:50 pm EDT Written by Zacks Equity Research for Zacks -> ...